Baidu
map
EPIDEMICS-NETH 润色咨询

Epidemics

出版年份：2009 年文章数：456 投稿命中率： 开通期刊会员，数据随心看

出版周期：Quarterly 自引率：3.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2143490, encodeId=a02721434906d, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=268f8743932, createdName=ms8000001501734461, createdTime=Sun Jun 18 11:53:35 CST 2023, time=2023-06-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2113341, encodeId=d5b12113341a9, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：传染病建模<br>经验分享：审稿很严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c48282337, createdName=ms8000000997643572, createdTime=Tue Feb 07 02:28:16 CST 2023, time=2023-02-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1104865, encodeId=d13a1104865dd, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104866, encodeId=131111048669a, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-06-18 ms8000001501734461 来自天津

    审稿速度:12.0 | 投稿命中率:50.0
    经验分享：严格

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2143490, encodeId=a02721434906d, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=268f8743932, createdName=ms8000001501734461, createdTime=Sun Jun 18 11:53:35 CST 2023, time=2023-06-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2113341, encodeId=d5b12113341a9, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：传染病建模<br>经验分享：审稿很严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c48282337, createdName=ms8000000997643572, createdTime=Tue Feb 07 02:28:16 CST 2023, time=2023-02-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1104865, encodeId=d13a1104865dd, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104866, encodeId=131111048669a, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-02-07 ms8000000997643572 来自北京

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：传染病建模
    经验分享：审稿很严格

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2143490, encodeId=a02721434906d, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=268f8743932, createdName=ms8000001501734461, createdTime=Sun Jun 18 11:53:35 CST 2023, time=2023-06-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2113341, encodeId=d5b12113341a9, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：传染病建模<br>经验分享：审稿很严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c48282337, createdName=ms8000000997643572, createdTime=Tue Feb 07 02:28:16 CST 2023, time=2023-02-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1104865, encodeId=d13a1104865dd, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104866, encodeId=131111048669a, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 桑晒麦拉

    讨论中局限性怎么撰写？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2143490, encodeId=a02721434906d, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=268f8743932, createdName=ms8000001501734461, createdTime=Sun Jun 18 11:53:35 CST 2023, time=2023-06-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2113341, encodeId=d5b12113341a9, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：传染病建模<br>经验分享：审稿很严格, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c48282337, createdName=ms8000000997643572, createdTime=Tue Feb 07 02:28:16 CST 2023, time=2023-02-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1104865, encodeId=d13a1104865dd, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104866, encodeId=131111048669a, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 Mia

    讨论中一般可以讨论什么？

    1

    展开1条回复
共6条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map